https://miasteniacampania.it/2026/02/12/neuroimmunologia-quando-il-sistema-nervoso-dialoga-con-il-sistema-immunitario/2026-02-25T13:53:40+01:00https://miasteniacampania.it/2026/02/24/miastenia-gravis-confermata-lefficacia-e-la-sicurezza-a-lungo-termine-diravulizumab/2026-02-25T10:47:24+01:00https://miasteniacampania.it/2026/02/23/inebilizumab-nuovi-risultati-positivi-nel-trattamento-della-miastenia-gravisgeneralizzata/2026-02-23T18:49:19+01:00https://miasteniacampania.it/2026/02/12/anche-in-italia-disponibile-lefgartigimod-in-formulazione-sottocutanea-per-lamiastenia-gravis/2026-02-12T17:37:29+01:00https://miasteniacampania.it/2026/02/12/rozanolixizumab-primo-farmaco-approvato-per-i-pazienti-con-miastenia-gravis-anti-musk/2026-02-12T17:20:25+01:00https://miasteniacampania.it/2026/02/12/miastenia-gravis-i-primi-dati-real-life-italiani-su-zilucoplan/2026-02-12T17:24:10+01:00